Drug Discovery Solutions
-
HEK293 Transient Production (Tuna293® Process)
6/5/2026
HEK293 cells have been the most popular mammalian transient production platform. The primary advantage of HEK293 cells is transfection efficiency.
-
Molecular Biology
5/28/2026
Our Biologics services provide comprehensive Molecular Biology services at facilities in California and Massachusetts, offering a variety of services.
-
Biological And Functional Assays
6/5/2026
Curia provides a wide range of biochemical and cell-based bioassay workflows to support Discovery, Research & Development as well as cGxP therapeutic testing campaigns
-
Analytical Labs Particle Analysis
Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
-
Scientific Insights Lab Simplifying The Journey From Molecule To Market
Drug development programs should aid customers in the successful mitigation of technical and regulatory risks to ensure drug products move swiftly through the regulatory approval process and into commercialization. Get service and support to help pharmaceutical and biopharmaceutical manufacturers Simplify the Journey™ from molecule to market.
-
TARGATT™ iPSC Kits
9/30/2025
Build cell-based models of disease and accelerate therapeutic development with TARGATT™ large knock-in technology in iPSCs.
-
iPSC Generation Services
9/30/2025
iPSC generation is a complex process of reprogramming adult somatic cells into a pluripotent, embryonic stem cell-like stage.
-
Bacterial Expression
6/5/2026
E. coli is often the system of choice for biomanufacturing because of its amenability to genetic manipulation, low production cost, and rapid timelines for bioexpression.
-
Recombinant Protein Production
5/28/2026
Curia has decades of experience in recombinant protein production.
-
Protein Expression And Analysis
5/28/2026
Curia’s expert scientists use advanced technology to produce and analyze high-quality recombinant proteins.